Publications by authors named "Simone Koole"

Claim this Profile
B
Budget Impact Analysis of Hyperthermic Intraperitoneal Chemotherapy With Interval Cytoreductive Surgery in Ovarian Cancer.
Madelief Schreuder Goedheijt, Ruby M van Stein, Simone N Koole, Gabe S Sonke, Willemien J van Driel

JCO Oncol Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1).
S Lot Aronson, Cédric Walker, Bram Thijssen, Koen K van de Vijver, Hugo M Horlings, Simone N Koole

Br J Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing dilemmas in the clinic: Lessons learned from biomarker-based drug development.
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Olga Kholmanskikh Van Criekingen, Simone Koole, David M Thomas, Hans Gelderblom

Cancer Cell· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in time to patient access to innovative cancer medicines in six European countries.
Julie M Vancoppenolle, Nora Franzen, Simone N Koole, Valesca P Retèl, Wim H van Harten

Int J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learned from postmarketing withdrawals of expedited approvals for oncology drug indications.
Simone N Koole, Atse H Huisman, Lonneke Timmers, Hans M Westgeest, Edwin van Breugel

Lancet Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.
S Lot Aronson, Marta Lopez-Yurda, Simone N Koole, Jules H Schagen van Leeuwen, Hendrik W R Schreuder

Lancet Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe.
Julie M Vancoppenolle, Simone N Koole, James F O'Mahony, Nora Franzen, Jacobus A Burgers

Drug Discov Today· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant immune checkpoint blockade revisited.
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Atse Huisman, Anke Pisters-van Roy, Simone Koole, Lonneke Timmers

Lancet Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial".
Simone N Koole, Philip C Schouten, Willemien J van Driel, Gabe S Sonke, Sabine C Linn

Int J Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial.
Simone N Koole, Philip C Schouten, Jan Hauke, Roel J C Kluin, Petra Nederlof

Int J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance.
Simone N Koole, Daan C L Vessies, Milou M F Schuurbiers, Astrid Kramer, Robert D Schouten

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study.
Jorne Ubachs, Simone N Koole, Max Lahaye, Cristina Fabris, Leigh Bruijs

Gynecol Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central radiology assessment of the randomized phase III open-label OVHIPEC-1 trial in ovarian cancer.
Simone N Koole, Leigh Bruijs, Cristina Fabris, Karolina Sikorska, Maurits Engbersen

Int J Gynecol Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.
Simone Koole, Ruby van Stein, Karolina Sikorska, Desmond Barton, Lewis Perrin

Int J Gynecol Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperthermic intraperitoneal chemotherapy for ovarian cancer: The heat is on.
Simone N Koole, Willemien J van Driel, Gabe S Sonke

Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial.
Simone N Koole, Christiaan van Lieshout, Willemien J van Driel, Evi van Schagen, Karolina Sikorska

J Clin Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
Willemien J van Driel, Simone N Koole, Gabe S Sonke

N Engl J Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
Willemien J van Driel, Simone N Koole, Karolina Sikorska, Jules H Schagen van Leeuwen, Henk W R Schreuder

N Engl J Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emphysematous cholecystitis due to Clostridium perfringens successfully treated by cholecystectomy.
Simone Nienke Koole, Bjorn Gerardus Petrus Maria Lohman, Josephus Marinus Jacobus van Unen

Acta Chir Belg· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis